A monoclonal antibody defines a novel HIV type 1 tat domain involved in trans-cellular trans-activation

AIDS Research and Human Retroviruses

Volumn 12, Issue 7, 1996, Pages 611-619

  Valvatne, Håvard ^a   Szilvay, Anne Marie ^a   Helland, Dag E ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; TRANSACTIVATOR PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN COS1; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; TRANSACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0029892264     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.611     Document Type: Article

References (36)

1. Sodroski J, Patarca R, Rosen C, Wong-Staal F, and Hasseltine WA: Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science 1985;229:74-77.
2. Peterlin MB, Luciw PA, Barr PJ, and Walker MD: Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci USA 1986;83: 9734-9738.
3. Muesing MA, Smith DH, and Capon DJ: Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 1987;48:691-701.
4. Li CJ, Friedman DJ, Wang C, Metelev V, and Pardee AB: Induction of Apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995;268:429-431.
5. Ruben S, Perkins A, Purcell R, Joung K, Sia R, Burghoff R, Hasseltine WA, and Rosen CA: Structural and functional characterization of human immunodeficiency virus tat protein. J Virol 1989;63:1-8.
6. Mhashilkar AM, Bagley J, Chen SY, Szilvay AM, Helland DE, and Marasco WA: Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies. EMBO J 1995;14:1542-1551.
7. Garcia JA, Harrich D, Pearson L, Mitsuyasu R, and Gaynor RB: Functional domains required fot Tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J 1988;7: 3143-3147.
8. Frankel AD, Chen L, Cotter RJ, and Pabo CO: Dimerization of the tat protein from human immunodeficiency virus: A cysteine-rich peptide mimics the normal metal-linked dimer interface. Proc Natl Acad Sci USA 1988;85:6297-6300.
9. Hauber J, Malim MH, and Cullen BR: Mutational analysis of the conserved basic domain of the human immunodeficiency virus tat protein. J Virol 1989;63:1181-1187.
10. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, and Valerio R: Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA 1989;86:6925-6929.
11. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, and Valerio R: HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J 1990;9:4145-4153.
12. Calnan BJ, Tidor B, Biancalana S, Hudson D, and Frankel AD: Argenine-mediated RNA recogiton: The argenine fork. Science 1991;252:1167-1171.
13. Siomi H, Shida H, Maki M, and Hatanaka M: Effects of a highly basic region of human immunodeficiency virus Tat protein on nuclear localization. J Virol 1990;64:1803-1807.
14. 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 1993;121:461-468.
15. Green M and Loewenstein PM: Autonomous functional domains of chemically synthesized human immunodeficiency virus tat transactivator protein. Cell 1988;55:1179-1188.
16. Frankel AD and Pabo CO: Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 1988;55:1189-1193.
17. Helland DE, Welles JL, Caputo A, and Haseltine WA: Trancellular transactivation by the human immunodeficiency virus type 1 Tat protein. J Virol 1991;65:4547-4549.
18. Marcuzzi A, Weinberger J, and Weinberger OK: Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J Virol 1992;66:4228-4232.
19. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, and Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (London) 1990;345:84-86.
20. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffel M, Cafaro A, Chang H-K, Brady JN, and Gallo RC: Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (London) 1994;371:674-680.
21. Brake DA, Debouck C, and Biesecker G: Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein. Tat. J Cell Biol 1990;111:1275-1281.
22. Hynes RO: Integrins: A family of cell surface receptors. Cell 1987;48:549-554.
23. Barillary G, Gendelman R, Gallo RC, and Ensoli B: The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 1993;90:7941-7945.
24. Mann DA and Frankel AD: Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 1991;10:1733-1739.
25. 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990;60:861-871.
26. Bergelson JM, Shepley MP, Chan BMC, Hemler ME, and Finberg RW: Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 1992;255:1718-1720.
27. Bergelson JM and Finberg RW: Intergins as receptors for virus attachment and cell entry. J Microbiol 1993;1:1-2.
28. Mason PW, Rieder E, and Baxt B: RGD sequence of foot-and-mooth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci USA 1994;91:1932-1936.
29. Hung C, Tang L, Perilli-Palmer P, Heiland DE, and Beltz GE: Expression and purification of biologically active recombinant HIV-1 Tat. Genetic structure and regulation of HIV. 1991;1:183-I91.
30. Felber BK and Pavlakis GN: A quantitative bioassay for HIV-1 based on transactivation. Science 1988;239:184-187.
31. Akrigg A, Wikinson GWG, Angliss S, and Greenway PJ: HIV-1 indicator cell lines. AIDS 1991;5:153-158.
32. Laemmli U: Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970;227:712-719.
33. Borer RA, Lehner CF, Eppenberger HM, and Nigg EA: Major nuclear proteins shuttle between nucleus and cytoplasm. Cell 1989;56:379-390.
34. Marasco WA, Szilvay AM, Kalland KH, Helland DE, Reyes HM, and Walter RJ: Spatial association of HIV-1 Tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells. Arc Virol 1994;139:133-154.
35. Cullen BR, Hauber J, Campbell K, Sodroski JG, Hasseltine WA, and Rosen CA: Subcellular localization of the human immunodeficiency virus trana-acting art gene product. J Virol 1988;62:2498-2501.
36. Cullen BR: Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 1986;46:973-982.